Mechanisms and assessment of statin-related muscular adverse effects. - sprookjes - yvandenbroek - TriplyDB

Mechanisms and assessment of statin-related muscular adverse effects.

Mechanisms and assessment of statin-related muscular adverse effects.

http://www.wikidata.org/entity/Q34570995

about

A Genomic DNA Reporter Screen Identifies Squalene Synthase Inhibitors That Act Cooperatively with Statins to Upregulate the Low-Density Lipoprotein Receptor Lovastatin-Mediated Changes in Human Tendon Cells A Peculiar Formula of Essential Amino Acids Prevents Rosuvastatin Myopathy in Mice.Colchicine triggered severe rhabdomyolysis after long-term low-dose simvastatin therapy: a case report Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database.The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy.Histopathologic and Biochemical Evidence for Mitochondrial Disease Among 279 Patients with Severe Statin Myopathy.Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib.Diagnostic confounders of chronic widespread pain: not always fibromyalgia.Genetic variation in human drug-related genes.Genetic and Clinical Factors Are Associated With Statin-Related Myotoxicity of Moderate Severity: A Case-Control Study.Statin therapy exacerbates alcohol-induced constriction of cerebral arteries via modulation of ethanol-induced BK channel inhibition in vascular smooth muscle.Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium.[Statin intolerance and associated muscular dysfunctions].Acute Onset Significant Muscle Weakness in a Patient Awaiting Liver Transplantation: Look for Statins.

P2860

Q33724316-1E255BDB-4BAD-4B55-A7B9-83FE81A31502 Q36799885-3195FE0E-03B7-4A87-85BB-F628D3F34569 Q37341027-D51A64B2-74D5-4E42-90A2-BD179D6CA9E7 Q37555163-CE90E406-F697-457A-9A30-AE3D0433C4BE Q38613096-C83C1E36-6D4D-4688-8571-FA7875485A4F Q38793280-983BDD8E-6A67-491F-BA8B-21090CAC72BF Q39166726-79C163C3-6240-4AEE-AE46-BCC7C1AA7852 Q40703907-453DE1FB-D1A8-4086-A441-74BCCB8EAD33 Q41024017-19C7931B-1201-49A4-A51C-1E8698E23C9F Q47552826-B0832E10-2559-46E7-84B9-5135D6C72ADE Q47564586-6C9A2D81-C43E-4E28-AEC3-627F7C4FED8E Q47676842-CB5BBFA5-DAEA-46C9-BA0F-0A5764B4D149 Q47865448-506B5790-FE69-4698-B6EA-A95F4FF14FA8 Q51752364-E8480C82-92CE-4A74-96B1-A94613C4AFAC Q53649484-682D1FB4-8E52-463B-A10C-CE50712A372C Q54067585-E798684A-E0C6-491F-911E-3304E1702CC9

P2860

Mechanisms and assessment of statin-related muscular adverse effects.

http://www.wikidata.org/entity/Q34570995

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mechanisms and assessment of statin-related muscular adverse effects.

@ast

Mechanisms and assessment of statin-related muscular adverse effects.

@en

Mechanisms and assessment of statin-related muscular adverse effects.

@nl

type

label

Mechanisms and assessment of statin-related muscular adverse effects.

@ast

Mechanisms and assessment of statin-related muscular adverse effects.

@en

Mechanisms and assessment of statin-related muscular adverse effects.

@nl

prefLabel

Mechanisms and assessment of statin-related muscular adverse effects.

@ast

Mechanisms and assessment of statin-related muscular adverse effects.

@en

Mechanisms and assessment of statin-related muscular adverse effects.

@nl

P1433

Q34570995-A56F0028-73AB-44AF-8A17-49CA11C93DE2

P1476

Q34570995-FEE7FF33-6722-4702-B4D7-B146FA4CE8DA

P2093

Q34570995-7F41C93D-AC73-4CDE-9676-DC3E04C6DC9D

Q34570995-B715682A-8667-470C-985E-43EBF225D0C1

Q34570995-E9080F30-B86F-4F55-B7AD-C989A4E166C4

P2860

Q34570995-00599B46-58B3-42D0-ADE1-AF15AAEE6F76

Q34570995-00D146DB-E0F5-40AA-8FB3-C041D097F9A9

Q34570995-01524296-3121-493E-84E8-591AE0CA0245

Q34570995-10B6F925-949E-47EA-AC36-8F8698737E53

Q34570995-11596C08-7554-41BF-AB90-5271C494E057

Q34570995-1AFF864D-8F2A-4D24-BB7D-46C5094AA989

Q34570995-214683C1-39DD-4F3B-92B1-55D2C930CF2F

Q34570995-228E7404-D5E1-4B7C-9F1D-18193EEE8407

Q34570995-25EAE0DB-6741-44A6-BB31-F00D00755201

Q34570995-281EE0B2-9540-4555-9F66-B6E88D297A93

P304

Q34570995-47573924-FF92-4846-8934-94C85367D95B

P31

Q34570995-88DD202D-A73B-4175-9812-01B51F702667

P356

Q34570995-B7859AFB-3DD4-4B8C-A142-F725A8BC7030

P407

Q34570995-AB66184A-E692-41BF-AD1C-1139B758302D

P433

Q34570995-B45A2603-BFC8-42E9-90F5-74A56921D8AF

P478

Q34570995-584AC77E-79A2-48BF-9EFD-70FA23B42F0F

P50

Q34570995-2AAE8F90-0727-4D88-82A5-6F056C2E40E8

P577

Q34570995-C5A5F5C8-16C6-4C3F-8BF3-45B63C66CD23

P5875

Q34570995-55E67A86-2B1A-4090-A2A6-66A7FB9561D0

P698

Q34570995-A911A841-98CD-40A7-8425-055B1EFC1FB3

P932

Q34570995-863A310D-8F85-4E79-992C-DE7235514D73

P356

P1433

British Journal of Clinical Pharmacology

P1476

Mechanisms and assessment of statin-related muscular adverse effects.

@en

P2093

Dirk Moßhammer

http://www.w3.org/2001/XMLSchema#string

Klaus Mörike

http://www.w3.org/2001/XMLSchema#string

Matthias Schwab

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic determinants of statin intolerance

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial

SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink

Association between statin-associated myopathy and skeletal muscle damage

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy

Human skeletal muscle drug transporters determine local exposure and toxicity of statins

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

P304

454-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12360

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Elke Schaeffeler

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264389393

http://www.w3.org/2001/XMLSchema#string

P698

25069381

http://www.w3.org/2001/XMLSchema#string

P932

4243897

http://www.w3.org/2001/XMLSchema#string